New evidence
Moringa linked to a moderate drop in diastolic blood pressure — but the meta-analysis rates the evidence as very low certainty.
This is the first pooled analysis on moringa and blood pressure, but with only three small trials and a 'very low' GRADE rating, the result is too shaky to act on — especially since other cardiometabolic outcomes didn't budge.
The analysis combined three randomized trials involving 341 adults and found that moringa supplements produced a modest reduction in diastolic blood pressure (the bottom number in a reading). However, the researchers flagged the overall evidence as very low certainty, meaning the finding could easily flip with better studies. Other heart-related measures like systolic blood pressure and cholesterol showed no consistent benefit, and the exact dose used wasn't reported.
Where this fits in the evidence
Pillser has synthesized 3 studies on Moringa for Reduced Diastolic Blood Pressure — overall evidence strength: Moderate.
Across 3 studies, all three reported beneficial effects on diastolic blood pressure, with effect sizes ranging from moderate to large. The highest-quality evidence, a meta-analysis of randomized controlled trials, found a moderate reduction (SMD -0.41, 95% CI -0.75 to -0.07). Two systematic reviews reported larger reductions (mean difference -6.82 to -7.32 mmHg). Study durations were not consistently reported, and no specific dose or form was identified.
The study
- Meta-Analysis
- n = 341
- 2025-11-07
- Nutrients
- PubMed: 41305552
- DOI: 10.3390/nu17223501
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.